Grant: CIHR Fellowship
Direct Payment
$100,000.00
IL-10-Dependent Mechanisms that Prevent the Development of Inflammatory Bowel Disease in Infants
FY 2014-15
Summary
The number of infant patients with inflammatory bowel disease (IBD) is rising in Canada. IBD in infants is often associated with a severe course unresponsive to conventional therapies. Genetic defects identified in infantile IBD patients can result in an inability to control intestinal inflammation. Recent work has credibly established that genetic defects leading to malfunction of a protein named interleukin 10 (IL-10) or its receptor (IL-10R) leads to the development of infantile IBD. Similarly, mice that lack IL-10 or IL-10R develop spontaneous colitis, making mice an ideal model to study human disease. Although the importance of IL-10 in controlling gut inflammation in adult mice is established, very little is known about the cellular sources of IL-10 and their role in preventing the onset of IBD during infancy. The purpose of this proposal is to identify the cells that produce IL-10 during infancy in the intestine, and to characterize the molecular mechanisms for induction of IL-10. I intend to define the role of these mechanisms in maintaining intestinal immune health and preventing IBD. Successful completion of this project will offer new avenues to develop therapies for infants with IBD.
Department
Program
CIHR Fellowship
Recipient
Location
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
319181
Name
Redhu Naresh S
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Partnername
Canadian Association of Gastroenterology (Oakville, Ontario)
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
IL-10-Dependent Mechanisms that Prevent the Development of Inflammatory Bowel Disease in Infants
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Host-Microbe Interaction; Immunoregulation; Inflammatory Bowel Disease; Microbiome; Mucosal Immunity
Abstract
The number of infant patients with inflammatory bowel disease (IBD) is rising in Canada. IBD in infants is often associated with a severe course unresponsive to conventional therapies. Genetic defects identified in infantile IBD patients can result in an inability to control intestinal inflammation. Recent work has credibly established that genetic defects leading to malfunction of a protein named interleukin 10 (IL-10) or its receptor (IL-10R) leads to the development of infantile IBD. Similarly, mice that lack IL-10 or IL-10R develop spontaneous colitis, making mice an ideal model to study human disease. Although the importance of IL-10 in controlling gut inflammation in adult mice is established, very little is known about the cellular sources of IL-10 and their role in preventing the onset of IBD during infancy. The purpose of this proposal is to identify the cells that produce IL-10 during infancy in the intestine, and to characterize the molecular mechanisms for induction of IL-10. I intend to define the role of these mechanisms in maintaining intestinal immune health and preventing IBD. Successful completion of this project will offer new avenues to develop therapies for infants with IBD.
Competitiondate
201411
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Redhu, Naresh S
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $100,000~ $0~